Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.49 |
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 3/20 | 0.42 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.42 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004649 | 0.82 | ALDH1A1 (0.73) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL505778 | 0.81 | ALDH1A1 (0.55) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL4485529 | 0.81 | ALDH1A1 (0.59) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL16242064 | 0.81 | ALDH1A1 (0.55) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL40709 | 0.80 | ALDH1A1 (0.59) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL3757670 | 0.80 | HPGD (0.58) | ALDH1A1HPGDSMN1; SMN2KMT2AMEN1 | |
| SCHEMBL3818379 | 0.79 | LOXL2 (0.55) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL3274471 | 0.79 | CA1 (0.55) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL7223619 | 0.79 | ALDH1A1 (0.53) | ALDH1A1HPGDSMN1; SMN2EPHX2NR1H4 | |
| SCHEMBL12482466 | 0.79 | NPSR1 (0.50) | ALDH1A1HPGDACACBHDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9631048-B2 | Sulfonium compounds, their preparation and use | BASF SE (DE) | 2017-04-25 | — | — | US | disclosed |
| CN-104379628-B | Sulfonium compound, it prepares and application thereof | 巴斯夫欧洲公司 | 2016-11-16 | — | — | CN | disclosed |
| EP-2838927-A2 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | BASF SE (DE) | 2015-02-25 | — | — | EP | disclosed |
| CN-104379628-A | Sulfonium compounds, their preparation and use | BASF SE | 2015-02-25 | — | — | CN | disclosed |
| US-20150044509-A1 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | BASF SE (DE) | 2015-02-12 | — | — | US | disclosed |
| US-20140005301-A1 | SULFONIUM SULFATES, THEIR PREPARATION AND USE | BASF SE (DE) | 2014-01-02 | — | — | US | disclosed |
| EP-2678311-A1 | SULFONIUM SULFATES, THEIR PREPARATION AND USE | BASF SE (DE) | 2014-01-01 | — | — | EP | disclosed |
| WO-2013156509-A2 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | BASF SE (DE) | 2013-10-24 | — | — | WO | disclosed |
| WO-2012113829-A1 | SULFONIUM SULFATES, THEIR PREPARATION AND USE | BASF SE (DE) | 2012-08-30 | — | — | WO | disclosed |
| EP-1004304-A1 | COMPOSITION CONTAINING ASCORBIC ACID | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2000-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044509-A1 | SULFONIUM COMPOUNDS, THEIR PREPARATION AND USE | SQOR, ACSL3, ARSA | ALDH1A1 573/4885HPGD 2808/4885SMN1; SMN2 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.